Chargement en cours...
Gabapentin attenuates somatic signs of precipitated THC withdrawal in mice
Cannabis is the most frequently used federally illicit substance in the United States. However, there are currently no FDA-approved pharmacotherapies to mitigate the withdrawal symptoms associated with cessation in heavy users. A promising, readily available non-cannabinoid therapy are the gabapenti...
Enregistré dans:
| Publié dans: | Neuropharmacology |
|---|---|
| Auteurs principaux: | , |
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
2021
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8204917/ https://ncbi.nlm.nih.gov/pubmed/33845073 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.neuropharm.2021.108554 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|